Expression of the tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancer

Ulrich Peter Rohr, Nina Rehfeld, Lucy Pflugfelder, Helene Geddert, Wolfram Müller, Ulrich G. Steidl, Roland Fenk, Thorsten Gräf, Matthias Schott, Klaus Peter Thiele, Helmut Erich Gabbert, Ulrich Germing, Ralf Kronenwett, Rainer Haas

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

In a retrospective analysis of 203 patients with small cell lung cancer (SCLC), we examined the prognostic value of c-kit expression on survival. Expression of c-kit was examined immunohistochemically in formalin-fixed, paraffin-embedded tissue sections. c-kit was observed in 87.7% of SCLC tumors. Using the Kaplan-Meier model, we found that lack of c-kit expression was associated with significantly shorter survival time compared to the presence of c-kit expression (mean survival 151 ± 27 vs. 358 ± 49 days, p = 0.0084). Moreover, the proportion of c-kit+ cells within the tumor was also related to survival time. Patients with tumors in which >75% of cells stained positive for c-kit had a mean overall survival time of 424 (±72) compared to 295 (±67) days for patients with 25-75% c-kit+ tumor cells. Patients with tumors containing <25% c-kit+ cells had the worst survival, with 164 (±24) days (p = 0.0033). Further parameters associated with short survival times were low performance status, elevated levels of lactate dehydrogenase and higher stage according to the TNM classification. Multivariate analysis using the Cox regression model showed that the proportion of c-kit+ cells within the tumor specimen was one of 3 independent prognostic parameters (p = 0.004) for overall survival next to TNM classification (p = 0.001) and performance status (p < 0.001).

Original languageEnglish (US)
Pages (from-to)259-263
Number of pages5
JournalInternational Journal of Cancer
Volume111
Issue number2
DOIs
StatePublished - Aug 20 2004
Externally publishedYes

Fingerprint

Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Survival
Neoplasms
Neoplasm Staging
L-Lactate Dehydrogenase
Proportional Hazards Models
Paraffin
Formaldehyde
Multivariate Analysis
Survival Rate

Keywords

  • C-kit
  • Multivariate analysis
  • Small cell lung cancer
  • Survival

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Expression of the tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancer. / Rohr, Ulrich Peter; Rehfeld, Nina; Pflugfelder, Lucy; Geddert, Helene; Müller, Wolfram; Steidl, Ulrich G.; Fenk, Roland; Gräf, Thorsten; Schott, Matthias; Thiele, Klaus Peter; Erich Gabbert, Helmut; Germing, Ulrich; Kronenwett, Ralf; Haas, Rainer.

In: International Journal of Cancer, Vol. 111, No. 2, 20.08.2004, p. 259-263.

Research output: Contribution to journalArticle

Rohr, UP, Rehfeld, N, Pflugfelder, L, Geddert, H, Müller, W, Steidl, UG, Fenk, R, Gräf, T, Schott, M, Thiele, KP, Erich Gabbert, H, Germing, U, Kronenwett, R & Haas, R 2004, 'Expression of the tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancer', International Journal of Cancer, vol. 111, no. 2, pp. 259-263. https://doi.org/10.1002/ijc.20252
Rohr, Ulrich Peter ; Rehfeld, Nina ; Pflugfelder, Lucy ; Geddert, Helene ; Müller, Wolfram ; Steidl, Ulrich G. ; Fenk, Roland ; Gräf, Thorsten ; Schott, Matthias ; Thiele, Klaus Peter ; Erich Gabbert, Helmut ; Germing, Ulrich ; Kronenwett, Ralf ; Haas, Rainer. / Expression of the tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancer. In: International Journal of Cancer. 2004 ; Vol. 111, No. 2. pp. 259-263.
@article{40de9a1a1bc84caab42c3eeffa0e821f,
title = "Expression of the tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancer",
abstract = "In a retrospective analysis of 203 patients with small cell lung cancer (SCLC), we examined the prognostic value of c-kit expression on survival. Expression of c-kit was examined immunohistochemically in formalin-fixed, paraffin-embedded tissue sections. c-kit was observed in 87.7{\%} of SCLC tumors. Using the Kaplan-Meier model, we found that lack of c-kit expression was associated with significantly shorter survival time compared to the presence of c-kit expression (mean survival 151 ± 27 vs. 358 ± 49 days, p = 0.0084). Moreover, the proportion of c-kit+ cells within the tumor was also related to survival time. Patients with tumors in which >75{\%} of cells stained positive for c-kit had a mean overall survival time of 424 (±72) compared to 295 (±67) days for patients with 25-75{\%} c-kit+ tumor cells. Patients with tumors containing <25{\%} c-kit+ cells had the worst survival, with 164 (±24) days (p = 0.0033). Further parameters associated with short survival times were low performance status, elevated levels of lactate dehydrogenase and higher stage according to the TNM classification. Multivariate analysis using the Cox regression model showed that the proportion of c-kit+ cells within the tumor specimen was one of 3 independent prognostic parameters (p = 0.004) for overall survival next to TNM classification (p = 0.001) and performance status (p < 0.001).",
keywords = "C-kit, Multivariate analysis, Small cell lung cancer, Survival",
author = "Rohr, {Ulrich Peter} and Nina Rehfeld and Lucy Pflugfelder and Helene Geddert and Wolfram M{\"u}ller and Steidl, {Ulrich G.} and Roland Fenk and Thorsten Gr{\"a}f and Matthias Schott and Thiele, {Klaus Peter} and {Erich Gabbert}, Helmut and Ulrich Germing and Ralf Kronenwett and Rainer Haas",
year = "2004",
month = "8",
day = "20",
doi = "10.1002/ijc.20252",
language = "English (US)",
volume = "111",
pages = "259--263",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Expression of the tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancer

AU - Rohr, Ulrich Peter

AU - Rehfeld, Nina

AU - Pflugfelder, Lucy

AU - Geddert, Helene

AU - Müller, Wolfram

AU - Steidl, Ulrich G.

AU - Fenk, Roland

AU - Gräf, Thorsten

AU - Schott, Matthias

AU - Thiele, Klaus Peter

AU - Erich Gabbert, Helmut

AU - Germing, Ulrich

AU - Kronenwett, Ralf

AU - Haas, Rainer

PY - 2004/8/20

Y1 - 2004/8/20

N2 - In a retrospective analysis of 203 patients with small cell lung cancer (SCLC), we examined the prognostic value of c-kit expression on survival. Expression of c-kit was examined immunohistochemically in formalin-fixed, paraffin-embedded tissue sections. c-kit was observed in 87.7% of SCLC tumors. Using the Kaplan-Meier model, we found that lack of c-kit expression was associated with significantly shorter survival time compared to the presence of c-kit expression (mean survival 151 ± 27 vs. 358 ± 49 days, p = 0.0084). Moreover, the proportion of c-kit+ cells within the tumor was also related to survival time. Patients with tumors in which >75% of cells stained positive for c-kit had a mean overall survival time of 424 (±72) compared to 295 (±67) days for patients with 25-75% c-kit+ tumor cells. Patients with tumors containing <25% c-kit+ cells had the worst survival, with 164 (±24) days (p = 0.0033). Further parameters associated with short survival times were low performance status, elevated levels of lactate dehydrogenase and higher stage according to the TNM classification. Multivariate analysis using the Cox regression model showed that the proportion of c-kit+ cells within the tumor specimen was one of 3 independent prognostic parameters (p = 0.004) for overall survival next to TNM classification (p = 0.001) and performance status (p < 0.001).

AB - In a retrospective analysis of 203 patients with small cell lung cancer (SCLC), we examined the prognostic value of c-kit expression on survival. Expression of c-kit was examined immunohistochemically in formalin-fixed, paraffin-embedded tissue sections. c-kit was observed in 87.7% of SCLC tumors. Using the Kaplan-Meier model, we found that lack of c-kit expression was associated with significantly shorter survival time compared to the presence of c-kit expression (mean survival 151 ± 27 vs. 358 ± 49 days, p = 0.0084). Moreover, the proportion of c-kit+ cells within the tumor was also related to survival time. Patients with tumors in which >75% of cells stained positive for c-kit had a mean overall survival time of 424 (±72) compared to 295 (±67) days for patients with 25-75% c-kit+ tumor cells. Patients with tumors containing <25% c-kit+ cells had the worst survival, with 164 (±24) days (p = 0.0033). Further parameters associated with short survival times were low performance status, elevated levels of lactate dehydrogenase and higher stage according to the TNM classification. Multivariate analysis using the Cox regression model showed that the proportion of c-kit+ cells within the tumor specimen was one of 3 independent prognostic parameters (p = 0.004) for overall survival next to TNM classification (p = 0.001) and performance status (p < 0.001).

KW - C-kit

KW - Multivariate analysis

KW - Small cell lung cancer

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=3142770459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142770459&partnerID=8YFLogxK

U2 - 10.1002/ijc.20252

DO - 10.1002/ijc.20252

M3 - Article

C2 - 15197780

AN - SCOPUS:3142770459

VL - 111

SP - 259

EP - 263

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 2

ER -